Health care stocks were rising premarket Friday with the iShares Biotechnology ETF (IBB) up 0.9% and the Health Care Select Sector SPDR Fund (XLV) 0.3% higher recently.
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) said the US Food and Drug Administration approved Dupixent for the treatment of adult patients with bullous pemphigoid. Shares of Sanofi and Regeneron Pharmaceuticals were up 1% pre-bell.
Madrigal Pharmaceuticals (MDGL) shares were up nearly 2% after the company said it received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for resmetirom to treat noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis.
Evolent Health (EVH) shares were nearly 2% higher after the company reiterated its Q2 and 2025 adjusted earnings before interest, taxes, depreciation and amortization guidance.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。